XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
2026 Notes
2023 Notes
2025 Notes
Common Stock
Common Stock
2023 Notes
Additional Paid-In Capital
Additional Paid-In Capital
2026 Notes
Additional Paid-In Capital
2023 Notes
Additional Paid-In Capital
2025 Notes
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at Jan. 31, 2019 $ 313,281       $ 6   $ 567,797       $ 335 $ (254,857)
Balance, shares at Jan. 31, 2019         60,455,381              
Cancellation of common stock issued from acquisitions, shares         (7,784)              
Issuance of common stock for employee share purchase plan 5,396           5,396          
Issuance of common stock for employee share purchase plan, shares         108,758              
Exercise of stock options 10,542       $ 1   10,541          
Exercise of stock options, shares         1,639,521              
Stock-based compensation expense 38,654           38,654          
Vested restricted stock units, shares         531,282              
Equity component of Notes, net of issuance costs       $ 246,967           $ 246,967    
Purchase of capped calls in relation to Notes       (118,738)           (118,738)    
Other comprehensive income (loss) (1,568)                   (1,568)  
Net loss (40,462)                     (40,462)
Balance at Jul. 31, 2019 454,072       $ 7   750,617       (1,233) (295,319)
Balance, shares at Jul. 31, 2019         62,727,158              
Balance at Apr. 30, 2019 319,166       $ 7   594,735       (251) (275,325)
Balance, shares at Apr. 30, 2019         61,640,573              
Exercise of stock options 6,060           6,060          
Exercise of stock options, shares         783,226              
Stock-based compensation expense 21,593           21,593          
Vested restricted stock units, shares         303,359              
Equity component of Notes, net of issuance costs       246,967           246,967    
Purchase of capped calls in relation to Notes       $ (118,738)           $ (118,738)    
Other comprehensive income (loss) (982)                   (982)  
Net loss (19,994)                     (19,994)
Balance at Jul. 31, 2019 454,072       $ 7   750,617       (1,233) (295,319)
Balance, shares at Jul. 31, 2019         62,727,158              
Balance at Jan. 31, 2020 445,657       $ 7   790,468       871 (345,689)
Balance, shares at Jan. 31, 2020         64,528,970              
Issuance of common stock for acquisitions 41,841           41,841          
Issuance of common stock for acquisitions, shares         432,634              
Issuance of common stock for employee share purchase plan 7,391           7,391          
Issuance of common stock for employee share purchase plan, shares         104,818              
Exercise of stock options 9,609           9,609          
Exercise of stock options, shares         987,804              
Stock-based compensation expense 58,756           58,756          
Vested restricted stock units, shares         658,285              
Equity component of Notes, net of issuance costs   $ 501,053           $ 501,053        
Purchase of capped calls in relation to Notes   (192,786)           (192,786)        
Settlement of Notes     $ (384,414)           $ (384,414)      
Settlement of Notes, shares           2,065,832            
Deferred tax related to convertible senior notes (9,588)           (9,588)          
Temporary equity reclassification (133)           (133)          
Other comprehensive income (loss) 7,462                   7,462  
Net loss (57,932)                     (57,932)
Balance at Jul. 31, 2020 426,916       $ 7   822,197       8,333 (403,621)
Balance, shares at Jul. 31, 2020         68,778,343              
Balance at Apr. 30, 2020 465,122       $ 7   822,713       2,907 (360,505)
Balance, shares at Apr. 30, 2020         66,827,590              
Issuance of common stock for acquisitions 41,841           41,841          
Issuance of common stock for acquisitions, shares         395,066              
Exercise of stock options 6,381           6,381          
Exercise of stock options, shares         582,946              
Stock-based compensation expense 34,209           34,209          
Vested restricted stock units, shares         360,130              
Equity component of Notes, net of issuance costs   501,053           501,053        
Purchase of capped calls in relation to Notes   $ (192,786)           $ (192,786)        
Settlement of Notes     $ (382,245)           $ (382,245)      
Settlement of Notes, shares           612,611            
Deferred tax related to convertible senior notes (9,588)           (9,588)          
Temporary equity reclassification 619           619          
Other comprehensive income (loss) 5,426                   5,426  
Net loss (43,116)                     (43,116)
Balance at Jul. 31, 2020 $ 426,916       $ 7   $ 822,197       $ 8,333 $ (403,621)
Balance, shares at Jul. 31, 2020         68,778,343